CFTR and cystic fibrosis: With a marked improvement in survival, the involvement of other organs, including hepatobiliary pathology, is currently coming into focus, as the underlying CF Transmembrane Conductance Regulator (CFTR) defect is equally expressed in biliary ducts and gallbladder epithelia.